sec filing
IM
NASDAQ · IMRX
Immuneering Corporation
Healthcare · Biotechnology
$5.04
Up+$0.02 (+0.40%)
Updated Sep 4, 2026, 6:20 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 224.71M
- P/E ratio
- -3.59
- Dividend yield
- 0.00%
- 52-week range
- $3.86 – $6.89
- Volume
- 424.43K
- Avg. volume
- 1.88M
Price performance
IMRX price history
1M range · 21 trading sessions · Daily adjusted prices
IMRX closed at $5.04 after 21 trading sessions, up 13.00% for the selected period.
- Last close
- $5.04
- Period change
- +13.00%
- Period low
- $4.46
- Period high
- $5.33
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 3, 2026 | $5.085 | $5.1049 | $4.93 | $5.04 | 424.43K |
| Sep 2, 2026 | $4.85 | $5.055 | $4.80 | $5.02 | 678.7K |
| Sep 1, 2026 | $4.90 | $4.985 | $4.84 | $4.85 | 435.18K |
| Aug 31, 2026 | $5.00 | $5.01 | $4.8625 | $4.99 | 587.88K |
| Aug 28, 2026 | $5.21 | $5.214 | $4.935 | $4.99 | 793.87K |
| Aug 27, 2026 | $5.19 | $5.395 | $5.12 | $5.21 | 788.39K |
| Aug 26, 2026 | $5.23 | $5.23 | $5.109 | $5.15 | 461.15K |
| Aug 25, 2026 | $5.20 | $5.38 | $5.20 | $5.23 | 364.3K |
| Aug 24, 2026 | $5.31 | $5.35 | $5.125 | $5.18 | 400.57K |
| Aug 21, 2026 | $5.31 | $5.43 | $5.2813 | $5.30 | 445.72K |
| Aug 20, 2026 | $5.25 | $5.37 | $5.20 | $5.25 | 473.16K |
| Aug 19, 2026 | $5.18 | $5.37 | $5.14 | $5.33 | 751.06K |
| Aug 18, 2026 | $5.14 | $5.20 | $4.96 | $5.03 | 512.52K |
| Aug 17, 2026 | $5.00 | $5.27 | $4.99 | $5.22 | 486.88K |
| Aug 14, 2026 | $5.18 | $5.18 | $4.93 | $5.06 | 524.22K |
| Aug 13, 2026 | $5.06 | $5.26 | $5.06 | $5.20 | 1.08M |
| Aug 12, 2026 | $4.82 | $5.095 | $4.73 | $5.07 | 902.99K |
| Aug 11, 2026 | $4.55 | $4.865 | $4.55 | $4.80 | 1.07M |
| Aug 10, 2026 | $4.52 | $4.65 | $4.51 | $4.53 | 706.84K |
| Aug 7, 2026 | $4.53 | $4.57 | $4.4298 | $4.51 | 723.27K |
| Aug 6, 2026 | $4.64 | $4.72 | $4.3501 | $4.46 | 772.32K |
Latest IMRX news
The latest Smart Investors Daily articles mentioning IMRX.
Stock researchCompany · Financials
Loading stock research…